Oracle's $50B AI Capex Surge Reinforces High-Stakes Bet Amid $553B Backlog Conversion Challenges

What happened

Oracle has ramped up its AI capital expenditures to $50 billion for FY26, as highlighted in recent news, aligning with its previously disclosed aggressive financing plan. This move is fueled by surging cloud growth, with Q3 FY26 IaaS revenue up 84% year-over-year and a massive $553 billion remaining performance obligation (RPO) backlog. However, only about 12% of this RPO is expected to be recognized as revenue in the next 12 months, creating a critical timing mismatch between spending and income. The company has secured funding through investment-grade bonds and equity-linked instruments, but this adds to a net debt of $93.3 billion and risks dilution via instruments like the up to $20B at-the-market program. This bold capex push aims to capture AI infrastructure demand but hinges on rapid capacity delivery and monetization, with execution risks looming large.

Implication

The increased capex underscores Oracle's aggressive pivot to AI infrastructure, but it heightens financial vulnerabilities due to elevated leverage and potential dilution from equity-linked financing. If RPO recognition stays below 12% or capacity additions falter from the recent 400MW per quarter, the bear case of $120 becomes more likely, driven by fixed lease commitments and funding costs. Conversely, successful acceleration in monetization could support revenue growth toward FY27 targets, aligning with the bull case of $190. Key near-term indicators to watch include the next-12-month RPO percentage, MW delivery per quarter, and liquidity usage such as commercial paper levels. Without clear improvement in these metrics, the investment remains speculative, reinforcing the 'WAIT' rating until evidence of sustainable conversion emerges.

Thesis delta

The news confirms Oracle's $50B AI capex plan, which was already central to the DeepValue report's analysis and does not fundamentally shift the thesis. It reinforces the existing view that investors must wait for tangible evidence of RPO conversion acceleration and capacity throughput before committing capital. The heightened focus on execution risks underscores the need for cautious monitoring, with no change to the core 'WAIT' recommendation until quarterly results demonstrate progress.